USANA Health Sciences (USNA)
NYSE Market Closed
USANA Health Sciences Inc. develops, manufactures, and sells nutritional supplements, functional foods, personal care products, and skincare items. The company focuses on health and wellness products, with an emphasis on science-based formulations intended to support nutrition, healthy living, and everyday personal care. Its portfolio includes vitamins, minerals, dietary supplements, meal and food products, and topical products sold under the USANA brand.
The company’s core nutritional business is organized around several operating areas, including buy-sell markets, China, and India, and it also reports a Hiya direct-to-consumer segment. Hiya expands USANA’s reach into children’s wellness products through an online consumer model, while the legacy business is known for direct selling and distributor-led customer relationships in many markets. This structure gives the company exposure to both traditional relationship-based wellness sales and newer digital commerce channels.
USANA operates internationally, with activity across Asia Pacific, the Americas, and Europe. Asia Pacific, particularly Greater China, is an important contributor to revenue and a key region for the company’s growth profile. As a result, the business is influenced by consumer health trends, local regulations governing supplements and direct selling, currency movements, and economic conditions in its major markets.
For investors, USNA represents a specialized consumer health and wellness company rather than a broad packaged-goods manufacturer. Its distinguishing features are in-house product development and manufacturing, a global direct-sales footprint, and a product mix centered on nutritional supplementation. The company’s performance depends on brand trust, distributor and customer engagement, regulatory compliance, and the continued appeal of wellness-oriented products in both established and emerging markets.
Last updated
- Market Cap
- 334.73M
- P/E
- 37.73
- P/FCF
- 113.05
- P/S
- 0.36
- Enterprise Value
- 185.98M
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Address
- 3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336
Women Health & Beauty Supplements Market Analysis and Growth Forecast 2026-2030
USNA or ZTS: Which Is the Better Value Stock Right Now?
USNA vs. ZTS: Which Stock Is the Better Value Option?
USNA vs. STVN: Which Stock Should Value Investors Buy Now?
USNA or STVN: Which Is the Better Value Stock Right Now?
USANA Health Sciences (USNA) Q1 Earnings and Revenues Top Estimates
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
USANA Health Sciences (USNA) Q3 Earnings Miss Estimates
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Earnings Preview: USANA Health Sciences (USNA) Q3 Earnings Expected to Decline
USNA or STVN: Which Is the Better Value Stock Right Now?
USNA vs. ZTS: Which Stock Is the Better Value Option?
USNA vs. ZTS: Which Stock Should Value Investors Buy Now?
USNA or ZTS: Which Is the Better Value Stock Right Now?
USANA Health Sciences (USNA) Tops Q2 Earnings and Revenue Estimates
All You Need to Know About USANA Health (USNA) Rating Upgrade to Buy
USANA Stock Could Bottom Soon
Usana sees sales bump in China, but 2023 still uncertain
USANA Health Sciences (USNA) Q2 Earnings and Revenues Lag Estimates
Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 334.73M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 185.98M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 37.73
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.62
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.36
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 2.28
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.2
- EPS
- 0.48
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0.41%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 113.05
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 20.13
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 2.96M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 1.63%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 1.2%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.03
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.51
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.69
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.39
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 112.87K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 18.13
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 250.22M | 226.2M | 213.67M | 235.85M | 249.54M |
| Gross profit | 190.78M | 176.79M | 164.86M | 185.66M | 197.09M |
| Operating income | 13.87M | 3.82M | 1.22M | 16.72M | 15.67M |
| EBITDA | 22.15M | 25.81M | 9.11M | 24.49M | 24.01M |
| Net income | 7.52M | -1.78M | -6.52M | 9.66M | 9.4M |
| Basic EPS | 0.41 | -0.09 | -0.36 | 0.52 | 0.49 |
| Diluted EPS | 0.41 | -0.09 | -0.36 | 0.52 | 0.49 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 738.97M | 742.92M | 726.59M | 734.53M | 746.6M |
| Total liabilities | 144.18M | 156.64M | 145.04M | 148.97M | 162.72M |
| Total equity | 543.55M | 533.1M | 528.07M | 531.06M | 529.76M |
| Cash & equivalents | 162.75M | 158.38M | 145.35M | 151.34M | 179.61M |
| Current assets | 294.23M | 288.41M | 264.07M | 261.87M | 281.39M |
| Current liabilities | 117.24M | 128.57M | 118.66M | 121.63M | 137.38M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 9.76M | -3.39M | -1.96M | 12.22M | 15.48M |
| Investing cash flow | -2.6M | 1.11M | -3.2M | -4.16M | -3.88M |
| Financing cash flow | -3.64M | 13.45M | -979K | -38.61M | -14.47M |
| Change in cash | 4.42M | 13.09M | -5.97M | -28.24M | -2.14M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| form 4 | Form 4 — Fleming John Turman | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 144 — USANA HEALTH SCIENCES INC | View Filing | |
| form 4 | Form 4 — Jones Paul A. | View Filing | |
| edgar index | 144 — USANA HEALTH SCIENCES INC | View Filing | |
| form 4 | Form 4 — IIEKKING G DOUG | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| form 4 | Form 4 — FULLER GILBERT A | View Filing | |
| edgar index | 8-K — USANA HEALTH SCIENCES INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 144 — USANA HEALTH SCIENCES INC | View Filing | |
| form 4 | Form 4 — FULLER GILBERT A | View Filing | |
| form 4 | Form 4 — WOOD TIMOTHY E | View Filing | |
| form 4 | Form 4 — Winssinger Frederic J | View Filing | |
| form 4 | Form 4 — Nixon J Scott | View Filing | |
| form 4 | Form 4 — Foukas Joshua | View Filing | |
| form 4 | Form 4 — Pelosi Peggie | View Filing | |
| form 4 | Form 4 — Fleming John Turman | View Filing | |
| form 4 | Form 4 — Ding Xia | View Filing | |
| edgar index | 8-K — USANA HEALTH SCIENCES INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| form 4 | Form 4 — FULLER GILBERT A | View Filing | |
| form 4 | Form 4 — FULLER GILBERT A | View Filing | |
| form 4 | Form 4 — WOOD TIMOTHY E | View Filing | |
| form 4 | Form 4 — WOOD TIMOTHY E | View Filing | |
| form 4 | Form 4 — WOOD TIMOTHY E | View Filing | |
| form 4 | Form 4 — Winssinger Frederic J | View Filing | |
| form 4 | Form 4 — Winssinger Frederic J | View Filing | |
| form 4 | Form 4 — Nixon J Scott | View Filing | |
| form 4 | Form 4 — Nixon J Scott | View Filing | |
| form 4 | Form 4 — Pelosi Peggie | View Filing | |
| form 4 | Form 4 — Pelosi Peggie | View Filing | |
| form 4 | Form 4 — Pelosi Peggie | View Filing | |
| form 4 | Form 4 — Fleming John Turman | View Filing | |
| form 4 | Form 4 — Fleming John Turman | View Filing | |
| form 4 | Form 4 — Ding Xia | View Filing | |
| form 4 | Form 4 — Ding Xia | View Filing | |
| form 4 | Form 4 — Ding Xia | View Filing | |
| edgar index | DEF 14A — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | ARS — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | SCHEDULE 13D/A — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | SCHEDULE 13G/A — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| form 4 | Form 4 — FULLER GILBERT A | View Filing | |
| edgar index | 10-K — USANA HEALTH SCIENCES INC | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 144 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing | |
| edgar index | 4 — USANA HEALTH SCIENCES INC | View Filing |